Neuland Laboratories approves dividend

16 May 2025 Evaluate
Neuland Laboratories has informed that the Board of Directors at their meeting held on even date, have considered and approved- the Audited Financial Results (Standalone & Consolidated) as per Indian Accounting Standards (IND AS) for the year ended March 31, 2025 along with Statement of Assets and Liabilities as on March 31, 2025 (enclosed). The Statutory Auditors of the Company, MSKA &. Associates, Chartered Accountants, have issued audit reports with unmodified opinion on the financial statements; Recommended payment of final dividend of Rs 12 (120 %) per equity share on a face value of Rs.10 each, for the financial year 2024-25. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 41st Annual General Meeting (AGM); Re-appointment of Davuluri Saharsh Rao (DIN: 02753145), as Whole Time Director, designated as Vice Chairman & Managing Director, for a further period of 5 (five) years, with effective from June 1, 2025, basis the recommendation of the Nomination and Remuneration Committee, subject to the approval of the shareholders of the Company in the ensuing AGM.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

16903.35 -85.15 (-0.50%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×